Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
David Solin Lee, EdD
Dr. David Solin Lee serves as the academic vice president of Alhambra Medical University. He earned a doctorate in education from UCLA and has served in senior leadership positions at several accredited traditional Asian medicine graduate programs since 1996.